How an Antibody Inhibits HIV-1 Integrase
Author Information
Author(s): Ramcharan Joseph, Colleluori Diana M, Merkel George, Andrake Mark D, Skalka Anna Marie
Primary Institution: The Institute for Cancer Research, Fox Chase Cancer Center
Hypothesis
Does the binding of mAb33 to HIV-1 integrase affect its activity and DNA binding?
Conclusion
The binding of mAb33 to HIV-1 integrase likely distorts the structure of the C-terminal domain, indirectly blocking substrate binding.
Supporting Evidence
- mAb33 binding prevents the metal-induced conformational change necessary for integrase activity.
- Alanine substitutions in the mAb33 epitope reduced antibody binding affinity.
- Some substitutions increased DNA binding affinity but led to non-specific nuclease activity.
Takeaway
Scientists studied an antibody that can stop HIV from working by changing the shape of a part of the virus's machinery, making it harder for the virus to insert its DNA into cells.
Methodology
The study involved creating monoclonal antibodies against HIV-1 integrase and testing their effects on the enzyme's activity and DNA binding using various assays.
Limitations
The exact spatial organization of the integrase domains within an active complex is not fully understood, which may limit the interpretation of the results.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website